Advanced thyroid cancer responds to targeted therapy with sunitinib
Sunday, March 8, 2015 - 12:00
in Health & Medicine
In patients with advanced thyroid cancer, sunitinib, a drug approved for treatment of several other cancers, showed significant cancer-fighting activity t, a new phase 2 clinical trial has found.